Fei Tang
6PUBLICATIONS
8CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Mar 08, 2026
Population Pharmacokinetic Analysis of Vixarelimab in Healthy Volunteers and Patients With Chronic Pruritic Conditions.Fei Tang, Steve Dang, Audrey Arjomandi
|Feb 11, 2025
Indication-Specific Dosing and Dose-Evaluation Strategies in New Indications for Non-Oncology Monoclonal Antibodies.Sherouk M Tawfik, Fei Tang
|Nov 22, 2024
Pharmacokinetic Modeling and Model-Based Hypothesis Generation for Dose Optimization of Clonidine in Neonates With Neonatal Opioid Withdrawal Syndrome.Fei Tang, Chee M Ng, Jamie Horn
|Jun 23, 2023
First-in-human phase 1 trial evaluating safety, pharmacokinetics, and pharmacodynamics of NLRP3 inflammasome inhibitor, GDC-2394, in healthy volunteers.Fei Tang, Rebecca Kunder, Tom Chu
|Oct 24, 2022
Population Pharmacokinetics of Tenecteplase in Patients With Acute Myocardial Infarction and Application to Patients With Acute Ischemic Stroke.Fei Tang, Jurgen Langenhorst, Steve Dang
|Mar 26, 2020
Using medical claims database to develop a population disease progression model for leuprorelin-treated subjects with hormone-sensitive prostate cancer.Yixuan Zou, Fei Tang, Jeffery C Talbert
Pageof 1
